Under terms of the agreement, Aphria shareholders will receive 0.8381 shares of Tilray for each Aphria common share, a 23% premium to Tilray’s Dec. 15 closing price of $7.87. The all-stock deal will create a new powerhouse in the pot industry, with an equity value of about C$4.8 billion ($3.8 billion).
The new company will trade under Tilray’s ticker on the Nasdaq, and Aphria shareholders will own 62% of Tilray’s stock under the terms of the transaction, which was characterized as a “reverse acquisition of Tilray,” the companies said.
Latest Videos From TheStreet and Jim Cramer:
- Coronavirus: The Latest Numbers on the COVID-19 Pandemic
- Streaming Isn't Enough to Make Jim Cramer Buy AT&T Stock
- What Stimulus Checks Do and Don’t Mean For Your Taxes
- Time Is Right for Airbnb, DoorDash IPOs, Asset Manager Says
- Drivers of Disruption and Innovation in the PPE Space
- Why Jim Cramer Is Confident on a Vaccine Rollout
- Jim Cramer: How to Balance Stay-At-Home and Return to Normal Plays